Assessing Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome: Unmet Needs

Danielle Brazel; Cecilia Larocca; Michi M Shinohara

doi:10.3390/cancers16152757

Assessing Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome: Unmet Needs

Cancers (Basel). 2024 Aug 3;16(15):2757. doi: 10.3390/cancers16152757.

Authors

Danielle Brazel¹, Cecilia Larocca², Michi M Shinohara³

Affiliations

¹ Department of Hematology/Oncology, Scripps Clinic/Scripps Green Hospital, La Jolla, CA 92037, USA.
² Brigham and Women's Department of Dermatology, Dana Farber Cancer Center, Boston, MA 02215, USA.
³ Department of Dermatology, University of Washington, 1959 Northeast Pacific Street BB-1353, Box 356524, Seattle, WA 98195, USA.

Abstract

Mycosis fungoides (MF) and Sézary syndrome (SS) can impair multiple dimensions of health-related quality of life (HRQoL). Currently, there is no standardized assessment tool for measuring HRQoL in patients with MF/SS. Here, we describe the existing literature on multiple dimensions of HRQoL in MF/SS with a special focus on the gaps in the current knowledge and identify future directions necessary to assess the HRQoL of patients with this disease.

Keywords: Sézary syndrome; health related quality of life; mycosis fungoides.

Publication types

Review

Grants and funding

No funding was secured for this report.